Revenues of Perspective Therapeutics, Inc. from 30 Jun 2016 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Perspective Therapeutics, Inc. quarterly and annual Revenues in USD history and change rate from 30 Jun 2016 to 30 Sep 2023.
  • Perspective Therapeutics, Inc. Revenues for the quarter ending 30 Sep 2023 was $2,185,000, a 27% increase year-over-year.
  • Perspective Therapeutics, Inc. annual Revenues for 2018 was $5,923,000, a 24% increase from 2017.
  • Perspective Therapeutics, Inc. annual Revenues for 2017 was $4,761,000, a 0.17% decline from 2016.
Source SEC data
View on sec.gov
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)

Perspective Therapeutics, Inc. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $2,185,000 +$468,000 +27% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $2,088,000 -$417,000 -17% 01 Apr 2023 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $2,063,000 -$847,000 -29% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q3 2022 $9,948,000 $1,717,000 -$847,000 -33% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $10,795,000 $2,505,000 -$205,000 -7.6% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023 2023 Q2
Q1 2022 $11,000,000 $2,910,000 +$310,000 +12% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $10,690,000 $2,816,000 +$457,000 +19% 01 Oct 2021 31 Dec 2021 10-K 28 Sep 2022 2022 FY
Q3 2021 $10,233,000 $2,564,000 +$180,000 +7.6% 01 Jul 2021 30 Sep 2021 10-K 28 Sep 2022 2022 FY
Q2 2021 $10,053,000 $2,710,000 +$431,000 +19% 01 Apr 2021 30 Jun 2021 10-K 28 Sep 2022 2022 FY
Q1 2021 $9,622,000 $2,600,000 -$280,000 -9.7% 01 Jan 2021 31 Mar 2021 10-K 28 Sep 2022 2022 FY
Q4 2020 $9,902,000 $2,359,000 +$153,000 +6.9% 01 Oct 2020 31 Dec 2020 10-K 28 Sep 2022 2022 FY
Q3 2020 $9,749,000 $2,384,000 +$69,000 +3% 01 Jul 2020 30 Sep 2020 10-K 28 Sep 2022 2022 FY
Q2 2020 $9,680,000 $2,279,000 +$355,000 +18% 01 Apr 2020 30 Jun 2020 10-K 27 Sep 2021 2021 FY
Q1 2020 $9,325,000 $2,880,000 +$956,000 +50% 01 Jan 2020 31 Mar 2020 10-K 27 Sep 2021 2021 FY
Q4 2019 $8,369,000 $2,206,000 +$302,000 +16% 01 Oct 2019 31 Dec 2019 10-K 27 Sep 2021 2021 FY
Q3 2019 $8,067,000 $2,315,000 +$753,000 +48% 01 Jul 2019 30 Sep 2019 10-K 27 Sep 2021 2021 FY
Q2 2019 $7,314,000 $1,924,000 +$321,000 +20% 01 Apr 2019 30 Jun 2019 10-K 25 Sep 2020 2020 FY
Q1 2019 $6,993,000 $1,924,000 +$351,000 +22% 01 Jan 2019 31 Mar 2019 10-K 25 Sep 2020 2020 FY
Q4 2018 $6,642,000 $1,904,000 +$368,000 +24% 01 Oct 2018 31 Dec 2018 10-K 25 Sep 2020 2020 FY
Q3 2018 $6,274,000 $1,562,000 +$351,000 +29% 01 Jul 2018 30 Sep 2018 10-K 25 Sep 2020 2020 FY
Q2 2018 $5,923,000 $1,603,000 +$233,000 +17% 01 Apr 2018 30 Jun 2018 10-K 27 Sep 2019 2019 FY
Q1 2018 $5,690,000 $1,573,000 +$291,000 +23% 01 Jan 2018 31 Mar 2018 10-K 27 Sep 2019 2019 FY
Q4 2017 $5,399,000 $1,536,000 +$508,000 +49% 01 Oct 2017 31 Dec 2017 10-K 27 Sep 2019 2019 FY
Q3 2017 $4,891,000 $1,211,000 +$130,000 +12% 01 Jul 2017 30 Sep 2017 10-K 27 Sep 2019 2019 FY
Q2 2017 $4,761,000 $1,370,000 01 Apr 2017 30 Jun 2017 10-K 26 Sep 2018 2018 FY
Q1 2017 $1,282,000 01 Jan 2017 31 Mar 2017 10-K 26 Sep 2018 2018 FY
Q4 2016 $1,028,000 01 Oct 2016 31 Dec 2016 10-K 26 Sep 2018 2018 FY
Q3 2016 $1,081,000 01 Jul 2016 30 Sep 2016 10-K 26 Sep 2018 2018 FY

Perspective Therapeutics, Inc. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2018 $5,923,000 +$1,162,000 +24% 01 Jul 2017 30 Jun 2018 10-K 26 Sep 2018 2018 FY
2017 $4,761,000 -$8,000 -0.17% 01 Jul 2016 30 Jun 2017 10-K 26 Sep 2018 2018 FY
2016 $4,769,000 01 Jul 2015 30 Jun 2016 10-K 26 Sep 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.